Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000357097-16-000128
Filing Date
2016-03-02
Accepted
2016-03-02 16:32:35
Documents
1
Period of Report
2016-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145695434261473.html 4  
1 FORM 4 wf-form4_145695434261473.xml 4 4137
  Complete submission text file 0000357097-16-000128.txt   5768
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 404 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address
Maslowski John Michael (Reporting) CIK: 0001608774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 161477516